1. QBT improved cognitive dysfunction in rats with vascular dementia by regulating the Nrf2/xCT/GPX4 and NLRP3/Caspase-1/GSDMD pathways to inhibit ferroptosis and pyroptosis of neurons.
- Author
-
Feng L, Wu YJ, Yang YR, Yue BJ, Peng C, Chen C, Peng F, Du JR, and Long FY
- Subjects
- Animals, Male, Rats, Neuroprotective Agents therapeutic use, Neuroprotective Agents pharmacology, Disease Models, Animal, Intracellular Signaling Peptides and Proteins metabolism, Humans, Gasdermins, Phosphate-Binding Proteins, NLR Family, Pyrin Domain-Containing 3 Protein metabolism, NF-E2-Related Factor 2 metabolism, Ferroptosis drug effects, Dementia, Vascular drug therapy, Dementia, Vascular metabolism, Dementia, Vascular psychology, Pyroptosis drug effects, Neurons drug effects, Neurons pathology, Neurons metabolism, Cognitive Dysfunction drug therapy, Cognitive Dysfunction metabolism, Phospholipid Hydroperoxide Glutathione Peroxidase metabolism, Caspase 1 metabolism, Rats, Sprague-Dawley, Signal Transduction drug effects
- Abstract
Background: The novel phthalein component QBT, extracted from Ligusticum chuanxiong, shows promising biological activity against cerebrovascular diseases. This study focused on ferroptosis and pyroptosis to explore the effects of QBT on nerve injury, cognitive dysfunction, and related mechanisms in a rat model of vascular dementia (VaD)., Methods: We established a rat model of VaD and administered QBT as a treatment. Cognitive dysfunction in VaD rats was evaluated using novel object recognition and Morris water maze tests. Neuronal damage and loss in the brain tissues of VaD rats were assessed with Nissl staining and immunofluorescence. Furthermore, we investigated the neuroprotective mechanisms of QBT by modulating the nuclear factor erythroid 2-related factor 2 (Nrf2)/cystine-glutamate antiporter (xCT)/glutathione peroxidase 4 (GPX4) and Nod-like receptor family pyrin domain-containing 3 (NLRP3)/cysteine-requiring aspartate protease-1 (Caspase-1)/Gasdermin D (GSDMD) pathways to inhibit ferroptosis and pyroptosis both in vivo and in vitro., Results: Our findings indicated that QBT significantly ameliorated neuronal damage and cognitive dysfunction in VaD rats. Additionally, QBT reversed abnormal changes associated with ferroptosis and pyroptosis in the brains of VaD rats, concurrently up-regulating the Nrf2/xCT/GPX4 pathway and down-regulating the NLRP3/Caspase-1/GSDMD pathway to inhibit ferroptosis and pyroptosis in neuronal cells, thereby exerting a neuroprotective role., Conclusion: In summary, QBT effectively mitigated neuronal damage and cognitive dysfunction in VaD rats, demonstrating a neuroprotective effect by inhibiting ferroptosis and pyroptosis in neuronal cells. This study offers a novel perspective and theoretical foundation for the future development of drugs targeting VaD., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF